MA-WASABI-TECHNOLOGIES
1.3.2023 14:16:58 CET | Business Wire | Press release
Wasabi Technologies is today releasing Part 3 of Wasabi’s 2023 Global Cloud Storage Index, analysing the key findings from EMEA-based organisations. The series, commissioned by Wasabi Technologies and conducted by Vanson Bourne, seeks to uncover the changing attitudes toward public cloud storage adoption, the factors that influence storage buying decisions, and the top priorities when it comes to budget, use cases, security, and cloud data migration.
“EMEA is an incredibly important segment of the overall cloud storage market. This global region and market have unique security, data movement, data sovereignty and accessibility requirements,” said Andrew Smith, senior manager of strategy and market intelligence at Wasabi Technologies, and a former IDC analyst. “These unique requirements can add complexity to cloud infrastructure decisions and migration initiatives. Nonetheless, our survey data indicates EMEA is poised to continue expanding both stored volumes in the cloud, as well as their cloud storage budgets, as we move further into 2023.”
According to the survey findings, 83% of EMEA respondents expect to increase the amount of data they store in the public cloud in the next year, and 81% plan to increase their budgets for public cloud storage. Additionally, the survey found that EMEA organisations are prioritising placement of data in cloud (both public and private) environments, as opposed to traditional IT environments. However, many EMEA organisations struggle to manage the fee and cost structures associated with public cloud storage.
EMEA prioritising cloud storage over on-premises storage, but security concerns remain paramount
- 87% of enterprises migrated storage from on-premises to public cloud in 2022, with Germany and the Netherlands exceeding the EMEA average at 98%, and 97% respectively. UK and France came in below the regional average at 78% and 85% respectively.
- 90% of EMEA enterprises expect the amount of data they store in the cloud to remain the same or increase in 2023.
- More resilient infrastructure (43%), avoiding costs on refreshing old or purchasing new hardware (40%), and need to scale resources (38%) were the top three factors driving migration from on-premises to cloud. France stood out from the rest of EMEA respondents, with access to global regions chosen as their top factor (44%)
- When it comes to cloud migration challenges by country, UK and Germany respondents both indicated that meeting compliance and regulatory requirements was their top issue.
- Regarding the specific regulatory requirements on the mind of EMEA respondents: GDPR was far and away the number one choice for UK organizations. France and Germany both ranked ISO standards at their top requirement
- In France 40% of the companies stated that the lack of cloud platform experience/insufficient training is their biggest security concern. UK respondents ranked unauthorised access or insight into one's data as their top security concern. Germany ranked lack of storage identity and access management policies/tools as their number one cloud storage security concern. And finally, respondents from Netherlands chose lack of native backup, DR, and data protection tools as their primary security concern.
- When it comes to cloud storage vendor selection criteria, EMEA also put security at the top of the list, ranking “data protection, security and compliance features/capabilities” as the number one consideration.
- However, there are important nuances by country. UK respondents indicated price / total cost of ownership is their top vendor selection consideration. In contrast, sustainability was the primary vendor selection criteria for France and Netherlands respondents.
EMEA enterprises plan to increase spending on cloud storage, but struggle with managing cost and fees
- EMEA enterprises allocate an average of 14% of their total IT budget to cloud storage, compared to the global average of 12%, and 81% plan to increase their cloud storage budget in 2023.
- IT initiatives (51%), business initiatives (47%) and new data security, backup and recovery requirements (43%) were the top three reasons driving budget increases in public cloud storage over the next 12 months.
- 52% of the EMEA organisations surveyed reported going over budget on public cloud storage spending over the last year, with the UK being the most efficient (only 45% of UK enterprises went over budget).
- Top reasons for EMEA orgs exceeding budget included: storage usage was higher than anticipated (39%); data operations fees were higher than forecast (37%); additional applications were migrated to the cloud (37%); storage list prices increased (37%); higher data retrieval (35%); API calls (31%); egress fees (26%) and more data deletion (26%) fees than expected.
- Overall, EMEA respondents indicate that 48% of their cloud storage bill is allocated to fees, and 51% allocated to storage capacity, on average. Netherlands indicated the highest proportional spend on fees at 51%, UK indicated the lowest at 45%.
“Today’s enterprises are required to be agile, and the insights gained from data lend a competitive advantage,” said Smith. “However, while the perceived value of enterprise data might be limitless, storing and accessing that data, on the other hand, has a very real cost. Unfortunately, the complexity and uncertainty of cloud storage fees can be a major challenge, and a key reason why more than half of organisations exceeded their cloud storage budget in 2022. This highlights a significant pain point for enterprises, and an opportunity to improve as they assess cloud storage spending for 2023.”
To read part one of the 2023 Wasabi Global Cloud Storage Index in its entirety, please visit our landing page.
Methodology
Wasabi commissioned the independent market research agency Vanson Bourne to conduct research into cloud storage. The study surveyed 1,000 IT decision-makers who had at least some involvement in or responsibility for public cloud storage purchases in their organization. Of the 1000 people surveyed, 350 (35%) were based in EMEA (specifically, France, Germany, the Netherlands and the UK).
The research took place in November and December 2022 from organisations with more than 100 employees across all public and private sectors. All interviews were conducted using a rigorous multi-level screening process to ensure that only suitable candidates were given the opportunity to participate.
About Wasabi Technologies
Wasabi provides simple and affordable hot cloud storage for businesses all over the world. It enables organizations to store and instantly access an unlimited amount of data with no complex tiers or egress or API fees, delivering predictable costs that save money and industry leading security and performance businesses can count on. Trusted by tens of thousands of customers worldwide, Wasabi has been recognized as one of technology’s fastest-growing and most visionary companies. Created by Carbonite co-founders and cloud storage pioneers David Friend and Jeff Flowers, Wasabi is a privately held company based in Boston. Wasabi is a Proud Partner of the Boston Red Sox, and the Official Cloud Storage Partner of Liverpool Football Club and the Boston Bruins.
Follow and connect with Wasabi on LinkedIn, Twitter, Facebook, Instagram, and The Bucket.
About Vanson Bourne
Vanson Bourne is an independent specialist in market research for the technology sector. Their reputation for robust and credible research-based analysis is founded upon rigorous research principles and their ability to seek the opinions of senior decision makers across technical and business functions, in all business sectors and all major markets.
For more information, visit: https://www.vansonbourne.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230301005122/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
